Introduction
Generalized tonic-clonic seizures (GTCSs) are commonly associated with central apnea and sustained sinus tachycardia. Potentially serious cardiac arrhythmias are very rare and include sinus bradycardia, asystole and ventricular tachyarrhythmia. 1 Here, we describe two patients with prolonged atrial fibrillation (AF) detected in the context of GTCSs. We review the previously reported cases and discuss possible pathophysiological mechanisms and treatment considerations.
Case reports

Case 1
This is a 23-year-old left-handed man with pharmacoresistant focal epilepsy since the age of 17 manifesting with infrequent variable auras (feeling ''unwell'', somewhat ''dizzy'' or being aware of tingling in the right or left hand) developing into secondarily GTCS (about 3 per year). Seizures had occurred from the sleeping and waking state and lasted between 2 and 3 min. Repeated routine scalp-EEG recordings were unremarkable. Cerebral MRI (3 T) and CT scan revealed multiple micro-calcifications at the junction of grey and white matter with an emphasis in the left parietal lobe. Although these findings together with presence of oligoclonal bands in the CSF were suggestive of neurocysticercosis or a chronic inflammatory process, subsequent extensive screening for specific antibodies (including HIV) in blood and CSF were normal and have not supported this hypothesis. Typical risk factors for epilepsy were absent (no febrile seizures, no head/brain injury, no known CNS inflammation, negative family history for epilepsy) and interictal neurological and general examinations were normal.
This patient was admitted to our hospital 45 min after a GTCS. Clinical examination was normal apart from an irregular heart rhythm with a rate of around 60 beats per minute (bpm). A 12-lead electrocardiogram (ECG) confirmed the presence of AF. Video-EEG telemetry was started 24 h after the GTCS and revealed no EEGabnormality during a 48-h recording period. During the recording period the patient was medicated with lamotrigine (LTG, 300 mg per day) and levetiracetam (LEV, 2000 mg per day). On the continuous one-lead ECG during video-EEG telemetry, AF was still present on the day after admission and spontaneously resolved about 25 h after the GTCS (Fig. 1 ). Blood pressure was normal (110-120/60-80 mm Hg, heart rate 60-70 bpm) during AF and did not change after the spontaneous remission of the AF. Cardiological evaluation with a transthoracic echocardiogram was normal (normal dimension of cardiac cavities without signs of atrial enlargement). The patient was given 100 mg aspirin per day and 47.5 mg metoprolol per day for some weeks. Repeated ambulatory Holter-recordings were recommended (but had not been done at last follow-up 5 months later). The LEV dose was increased to A B S T R A C T We describe two male patients with focal epilepsy in whom transitory episodes of atrial fibrillation (AF) lasting for up to 25 h were detected in the context of generalized tonic-clonic seizures (GTCSs). In five of seven previously published cases of transitory AF associated with epileptic seizures, AF was also associated with GTCS, suggesting a pathophysiological link via GTCS-related increase in sympathetic tone and release of catecholamines. Importantly, AF increases the risk of thromboembolic cerebral ischemia, prompting the question of whether antithrombotic preventive treatment should be initiated in people with pharmacoresistant epilepsy and prolonged peri-ictal AF. Furthermore, AF can considerably impair cardiac output and may, via this mechanism, contribute to the risk of sudden unexpected death in epilepsy following GTCS.
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3000 mg per day to improve seizure control. Interestingly, three years prior to the current admission, cardiological examinations were already performed because of transitory AF with rapid heart rate in the context of a GTCS (while taking 250 mg LTG per day). All subsequent examinations including transthoracic echocardiogram, 24 h Holterrecording and exercise testing carried out at that time were normal.
Case 2
This is a 25-year-old right-handed man with pharmacoresistant focal epilepsy since the age of 7 manifesting with complex-partial seizures (staring, impaired consciousness and complex automatisms or acoustic auras and sensory aphasia). On LTG (400 mg per day), LEV (4000 mg per day) and valproate (1000 mg per day) seizures occurred in clusters with a frequency of about 3 per week and a duration of 1-2 min. In addition, the patient reported 6-12 secondarily GTCSs a year. Cerebral MRI (3 T) revealed a mesiotemporal dysembryoplastic tumor of the left hemisphere. In view of concordant electro-clinical and MRI findings, the patient underwent epilepsy surgery (resection of the anterior temporal lobe including mesio-temporal structures). At the time of his last follow-up 6 months after epilepsy surgery he was seizure-free on LTG (500 mg per day) and LEV (3000 mg per day).
Prior to epilepsy surgery, this patient had suffered from a GTCS causing a minor head injury and laceration of the scalp, prompting referral to an adjacent hospital. On admission into the intensive care unit, he presented with rapid AF which spontaneously resolved after several hours. Based on the time of seizure-onset and arrival in the hospital, the estimated duration of AF amounted to a minimum of 3 h. Blood pressure was normal or transiently elevated (up to 170/60 mm Hg) during and after the AF episode. Additional cardiological examinations, apart from a 12-lead ECG, have not been performed. At the time of this episode, the patient was on LEV (3000 mg per day), LTG (300 mg per day) and lacosamide (LCM, 100 mg per day).
Discussion
Sinus tachycardia is frequently observed during or after seizures, whereas peri-ictal bradyarrhythmias including sinus bradycardia and asystole, atrioventricular conduction block and marked sinus arrhythmia are less common.
1,2 Seizure-related AF appears to be very rare and is usually of short duration. To date, only a few episodes of AF lasting up to 2 h have been reported in people with epilepsy (Table 1) . Here, we describe two patients with chronic epilepsy in whom prolonged episodes of AF lasting up to 25 h were detected in the context of GTCSs.
Study limitations
The major weakness of our cases is the fact that the onset of AF has not been recorded during continuous video-EEG telemetry, but that AF was only recognized on admission in the hospital after a GTCS at home. It is important to note that AF is clinically silent without any symptoms in about one third of people with AF. 3 Thus, we cannot rule out that in our two patients AF has occurred independently of the generalized seizures. Known triggering or facilitating factors of AF such as thyroid dysfunction, excessive alcohol-consumption or other medical conditions associated with AF were not present in our patients. 4, 5 Anticonvulsant drugs may also facilitate the onset of AF. For instance LCM has recently been reported to be associated with AF in a patient with epilepsy on 600 mg LCM per day. 6 In this patient, AF remitted on discontinuation of LCM. In our case 2, AF was detected following a GTCS while the patient was on three anticonvulsant drugs including LCM. Although LCM was used at a low dose, a causal or permissive relationship between LCM administration and onset of AF cannot be ruled out.
Pathophysiological mechanism of seizure-related AF
Seven cases of seizure-related AF have previously been reported (Table 1) . [7] [8] [9] [10] [11] In five of these patients, AF was detected in the context of GTCS (one seizure type was not reported). Thus, 7 of 9 cases of seizure-related AF were recognized following GTCSs, strongly suggesting a pathophysiological link between the onset of AF and GTCS. This apparent association, however, could also be due to a selection bias for GTCS, as these patients are often immediately referred to a hospital where ECG recordings are routinely performed on admission. Nevertheless, several arguments are in favor of the hypothesis that AF was induced by GTCSs in our two patients: (i) Both patients have denied interictal symptoms suggestive of cardiac arrhythmia such as palpitations or syncope (although this is a weak point, since up to one third of people with AF have no clinical symptoms) 3 ; (ii) both patients had no apparent cardiological disease, and interictal cardiac diagnostic work-up including cardiac Holter-monitoring in the absence of GTCS was normal; (iii) in our patient 1, AF was detected twice following GTCSs. Repeated AF after GTCS was also recently described by Vedovello et al. 7 ; (iv) GTCSs are associated with a massive release of catecholamines 12 ; (v) adrenergic/sympathetic stimulation is implicated in the generation of AF, 13, 14 potentially linking GTCS and occurrence of AF.
Clinical implications and treatment considerations
Paroxysmal or permanent AF is an important risk factor for thromboembolic ischemic stroke. 15 Furthermore, irregular heart activity with slow or fast heart rate may impair cardiac output with consecutive clinical symptoms. Thus, increased mortality, an increased risk for stroke and potential impairment of cardiac function prompt the questions if and how transient seizure-related AF has to be treated. Medical treatment of AF basically involves antithrombotic treatment on the one hand and the control of heart rate and rhythm on the other hand. 4 In view of the young age of our two patients and the absence of other risk factors, the stroke risk was low, so that permanent antithrombotic medication was not thought to be indicated. 15 In this context, it is important to stress that antithrombotic treatment in people with frequent GTCSs and consecutive falls should be considered with caution and, in view of the increased risk of head injury and intracranial hemorrhage, may better be avoided. The management of heart rate and rhythm includes the question of whether conversion of AF into sinus rhythm is necessary and whether potential alterations of heart rate lead to symptoms. Cardiological conversion therapy and long-term administration of drugs for rate control were not considered in our two cases, as AF reconverted spontaneously. In view of the probable pathophysiological link between GTCS, adrenergic/ sympathetic hyperactivity and onset of AF, however, long-term administration of beta-blockers (which are commonly used for rate and rhythm control in people with AF) may be considered in people with pharmacoresistant epilepsy and seizure-related AF. Our findings may also be of some importance in the context of sudden unexpected death in epilepsy (SUDEP). AF is associated with increased mortality predominantly due to complications of ischemic stroke. 16 AF, however, can also cause considerable impairment of ventricular output (especially with tachycardia) even in the absence of structural heart disease. 3 Therefore, periictal AF may also contribute to an increased risk of SUDEP; GTCS being a major risk factor for SUDEP. 1 Interestingly, peri-ictal AF has been observed in two patients who died of SUDEP later on (Table  1) , supporting the hypothesis of a potential contribution of AF to SUDEP. 10 In conclusion, transitory AF is a rare complication of GTCSs. It is unclear whether seizure-related AF requires specific treatment.
The best prevention appears to be full seizure-control. Interdisciplinary care may be considered in people with chronic epilepsy, repeated episodes of prolonged peri-ictal AF and co-factors which are associated with an increased risk of thromboembolic stroke or disturbances of heart rate with consecutive complications. 15 
